Cargando…
Assessment of Advanced Glycation End Products and Receptors and the Risk of Dementia
IMPORTANCE: Advanced glycation end products (AGEs) and their receptor (RAGE) are implicated in the pathophysiological processes of dementia and potentially underlie the association of diabetes with neurodegeneration. However, longitudinal studies examining this association are lacking. OBJECTIVE: To...
Autores principales: | Chen, Jinluan, Mooldijk, Sanne S., Licher, Silvan, Waqas, Komal, Ikram, M. Kamran, Uitterlinden, André G., Zillikens, M. Carola, Ikram, M. Arfan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7794665/ https://www.ncbi.nlm.nih.gov/pubmed/33416887 http://dx.doi.org/10.1001/jamanetworkopen.2020.33012 |
Ejemplares similares
-
Skin Autofluorescence, a Noninvasive Biomarker for Advanced Glycation End-products, Is Associated With Sarcopenia
por: Waqas, Komal, et al.
Publicado: (2021) -
Letter to the Editor, Reacting to: “APOE ε4 Carriers Have a Greater Propensity to Glycation and sRAGE Which Is Further Influenced by RAGE G82S Polymorphism”
por: Mooldijk, Sanne S, et al.
Publicado: (2020) -
Advanced glycation end products measured by skin autofluorescence and subclinical cardiovascular disease: the Rotterdam Study
por: Chen, Jinluan, et al.
Publicado: (2023) -
Dietary Advanced Glycation End-Products (dAGEs) Intake and Bone Health: A Cross-Sectional Analysis in the Rotterdam Study
por: Waqas, Komal, et al.
Publicado: (2020) -
The association between dietary and skin advanced glycation end products: the Rotterdam Study
por: Chen, Jinluan, et al.
Publicado: (2020)